{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36968055", "DateRevised": {"Year": "2023", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.1039/d3ra00526g"], "Journal": {"ISSN": "2046-2069", "JournalIssue": {"Volume": "13", "Issue": "14", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "20"}}, "Title": "RSC advances", "ISOAbbreviation": "RSC Adv"}, "ArticleTitle": "Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation.", "Pagination": {"StartPage": "9513", "EndPage": "9529", "MedlinePgn": "9513-9529"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD), a neurodegenerative condition associated with ageing, can occur. AD gradually impairs memory and cognitive function, which leads to abnormal behavior, incapacity, and reliance. By 2050, there will likely be 100 million cases of AD in the world's population. Acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition are significant components of AD treatment. This work developed models using the genetic method multiple linear regression, atom-based, field-based, and 3-D pharmacophore modelling. Due to internal and external validation, all of the models have solid statistical (<i>R</i> <sup>2</sup> > 0.81 and <i>Q</i> <sup>2</sup> > 0.77) underpinnings. From a pre-plated CNS library (6055), we discovered a hit compound using virtual screening on a QSAR model. Through molecular docking, additional hit compounds were investigated (XP mode). Finally, a molecular dynamics simulation revealed that the Molecule5093-4BDS complex was stable (100 ns). Finally, the expected ADME properties for the hit compounds (Molecule5093, Molecule1076, Molecule4412, Molecule1053, and Molecule3344) were found. According to the results of our investigation and the prospective hit compounds, BuChE inhibitors may be used as a treatment for AD."], "CopyrightInformation": "This journal is \u00a9 The Royal Society of Chemistry."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "Kumar", "ForeName": "Sunil", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "Manoharan", "ForeName": "Amritha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "J", "ForeName": "Jayalakshmi", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University Sakaka 72341 Saudi Arabia bijomathew@aims.amrita.edu bijovilaventgu@gmail.com aneeshtp@aims.amrita.edu."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University Beni-Suef Egypt."}], "LastName": "Abdelgawad", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Saud University Riyadh 11451 Saudi Arabia."}], "LastName": "Mahdi", "ForeName": "Wael A", "Initials": "WA"}, {"Identifier": ["0000-0002-0922-9819"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Saud University Riyadh 11451 Saudi Arabia."}], "LastName": "Alshehri", "ForeName": "Sultan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University Ad Diriyah 13713 Saudi Arabia."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, Al-Azhar University Cairo 11884 Egypt."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "Pappachen", "ForeName": "Leena K", "Initials": "LK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "Zachariah", "ForeName": "Subin Mary", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "Aneesh", "ForeName": "T P", "Initials": "TP"}, {"Identifier": ["0000-0002-6658-4497"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus Kochi 682 041 India."}], "LastName": "Mathew", "ForeName": "Bijo", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "RSC Adv", "NlmUniqueID": "101581657", "ISSNLinking": "2046-2069"}, "CommentsCorrectionsList": [{"RefSource": "RSC Adv. 2023 Apr 6;13(16):10956. doi: 10.1039/d3ra90030d", "PMID": "37033440"}], "CoiStatement": "There is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lane C. A. Hardy J. Schott J. M. Alzheimer's Disease. Eur. J. Neurol. 2018;25(1):59\u201370. doi: 10.1111/ene.13439.", "ArticleIdList": ["10.1111/ene.13439", "28872215"]}, {"Citation": "Imbimbo B. P. Lombard J. Pomara N. Pathophysiology of Alzheimer's Disease. Neuroimaging Clin. North Am. 2005;15(4):727\u2013753. doi: 10.1016/j.nic.2005.09.009.", "ArticleIdList": ["10.1016/j.nic.2005.09.009", "16443487"]}, {"Citation": "\u015eenol F. S. Orhan \u0130. Yilmaz G. \u00c7i\u00e7ek M. \u015eener B. Acetylcholinesterase, Butyrylcholinesterase, and Tyrosinase Inhibition Studies and Antioxidant Activities of 33 Scutellaria L. Taxa from Turkey. Food Chem. Toxicol. 2010;48(3):781\u2013788. doi: 10.1016/j.fct.2009.12.004.", "ArticleIdList": ["10.1016/j.fct.2009.12.004", "20026160"]}, {"Citation": "Uddin R. Yuan H. Petukhov P. A. Choudhary M. I. Madura J. D. Receptor-Based Modeling and 3-D QSAR for a Quantitative Production of the Butyrylcholinesterase Inhibitors Based on Genetic Algorithm. J. Chem. Inf. Model. 2008;48(5):1092\u20131103. doi: 10.1021/ci8000056.", "ArticleIdList": ["10.1021/ci8000056", "18444627"]}, {"Citation": "Pang X. Fu H. Yang S. Wang L. Liu A.-L. Wu S. Du G.-H. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer\u2019s Disease Agents Using Pharmacophore, 3-D QSAR, and Molecular Docking Approaches. Molecules. 2017;22(8):1254. doi: 10.3390/molecules22081254.", "ArticleIdList": ["10.3390/molecules22081254", "PMC6152156", "28933746"]}, {"Citation": "Greig N. H. Lahiri D. K. Sambamurti K. Butyrylcholinesterase An Important New Target in Alzheimer's Disease Therapy. Int. Psychogeriatr. 2002;14(S1):77\u201391. doi: 10.1017/S1041610203008676.", "ArticleIdList": ["10.1017/S1041610203008676", "12636181"]}, {"Citation": "Cummings J. L. Morstorf T. Zhong K. Alzheimer's Disease Drug-Development Pipeline: Few Candidates, Frequent Failures. Alzheimer's Res. Ther. 2014;6(4):37. doi: 10.1186/alzrt269.", "ArticleIdList": ["10.1186/alzrt269", "PMC4095696", "25024750"]}, {"Citation": "Greig N. H. Utsuki T. Ingram D. K. Wang Y. Pepeu G. Scali C. Yu Q.-S. Mamczarz J. Holloway H. W. Giordano T. Chen D. Furukawa K. Sambamurti K. Brossi A. Lahiri D. K. Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer \u03b2-Amyloid Peptide in Rodent. Proc. Natl. Acad. Sci. 2005;102(47):17213\u201317218. doi: 10.1073/pnas.0508575102.", "ArticleIdList": ["10.1073/pnas.0508575102", "PMC1288010", "16275899"]}, {"Citation": "Ko\u0161ak U. Brus B. Knez D. \u0160ink R. \u017dakelj S. Trontelj J. Pi\u0161lar A. \u0160lenc J. Gobec M. \u017divin M. Tratnjek L. Per\u0161e M. Sa\u0142at K. Podkowa A. Filipek B. Nachon F. Brazzolotto X. Wi\u0119ckowska A. Malawska B. Stojan J. Ra\u0161\u010dan I. M. Kos J. Coquelle N. Colletier J.-P. Gobec S. Development of an In-Vivo Active Reversible Butyrylcholinesterase Inhibitor. Sci. Rep. 2016;6(1):39495. doi: 10.1038/srep39495.", "ArticleIdList": ["10.1038/srep39495", "PMC5175178", "28000737"]}, {"Citation": "Reid G. A. Darvesh S. Butyrylcholinesterase-Knockout Reduces Brain Deposition of Fibrillar \u03b2-Amyloid in an Alzheimer Mouse Model. Neuroscience. 2015;298:424\u2013435. doi: 10.1016/j.neuroscience.2015.04.039.", "ArticleIdList": ["10.1016/j.neuroscience.2015.04.039", "25931333"]}, {"Citation": "Darvesh S. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease. Curr. Alzheimer Res. 2016;13(10):1173\u20131177. doi: 10.2174/1567205013666160404120542.", "ArticleIdList": ["10.2174/1567205013666160404120542", "27040140"]}, {"Citation": "Chierrito T. P. C. Pedersoli-Mantoani S. Roca C. Sebastian-P\u00e9rez V. Mart\u00ednez-Gonzalez L. P\u00e9rez D. I. Perez C. Canales A. Ca\u00f1ada F. J. Campillo N. E. Carvalho I. Martinez A. Chameleon-like Behavior of Indolylpiperidines in Complex with Cholinesterases Targets: Potent Butyrylcholinesterase Inhibitors. Eur. J. Med. Chem. 2018;145:431\u2013444. doi: 10.1016/j.ejmech.2018.01.007.", "ArticleIdList": ["10.1016/j.ejmech.2018.01.007", "29335209"]}, {"Citation": "Darvesh S. Hopkins D. A. Geula C. Neurobiology of Butyrylcholinesterase. Nat. Rev. Neurosci. 2003;4(2):131\u2013138. doi: 10.1038/nrn1035.", "ArticleIdList": ["10.1038/nrn1035", "12563284"]}, {"Citation": "Masson P. Carletti E. Nachon F. Structure, Activities and Biomedical Applications of Human Butyrylcholinesterase. Protein Pept. Lett. 2009;16(10):1215\u20131224. doi: 10.2174/092986609789071207.", "ArticleIdList": ["10.2174/092986609789071207", "19508180"]}, {"Citation": "Lockridge O., Duysen E. G. and Masson P., Butyrylcholinesterase: Overview, Structure, and Function, in Anticholinesterase Pesticides, John Wiley & Sons, Inc., Hoboken, NJ, USA, 2011, pp. 25\u201341, 10.1002/9780470640500.ch3", "ArticleIdList": ["10.1002/9780470640500.ch3"]}, {"Citation": "Doorn J. A. Talley T. T. Thompson C. M. Richardson R. J. Probing the Active Sites of Butyrylcholinesterase and Cholesterol Esterase with Isomalathion: Conserved Stereoselective Inactivation of Serine Hydrolases Structurally Related to Acetylcholinesterase. Chem. Res. Toxicol. 2001;14(7):807\u2013813. doi: 10.1021/tx015501s.", "ArticleIdList": ["10.1021/tx015501s", "11453726"]}, {"Citation": "Nachon F. L. Nicolet Y. Masson P. Structure Tridimensionnelle de La Butyrylcholinest\u00e9rase Humaine. Ann. Pharm. Fr. 2005;63(3):194\u2013206. doi: 10.1016/S0003-4509(05)82274-6.", "ArticleIdList": ["10.1016/S0003-4509(05)82274-6", "15976688"]}, {"Citation": "Nicolet Y. Lockridge O. Masson P. Fontecilla-Camps J. C. Nachon F. Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products. J. Biol. Chem. 2003;278(42):41141\u201341147. doi: 10.1074/jbc.M210241200.", "ArticleIdList": ["10.1074/jbc.M210241200", "12869558"]}, {"Citation": "Lockridge O. Review of Human Butyrylcholinesterase Structure, Function, Genetic Variants, History of Use in the Clinic, and Potential Therapeutic Uses. Pharmacol. Ther. 2015;148:34\u201346. doi: 10.1016/j.pharmthera.2014.11.011.", "ArticleIdList": ["10.1016/j.pharmthera.2014.11.011", "25448037"]}, {"Citation": "Macdonald I. R. Martin E. Rosenberry T. L. Darvesh S. Probing the Peripheral Site of Human Butyrylcholinesterase. Biochemistry. 2012;51(36):7046\u20137053. doi: 10.1021/bi300955k.", "ArticleIdList": ["10.1021/bi300955k", "PMC3438789", "22901043"]}, {"Citation": "Nachon F. Ehret-Sabatier L. Loew D. Colas C. van Dorsselaer A. Goeldner M. Trp82 and Tyr332 Are Involved in Two Quaternary Ammonium Binding Domains of Human Butyrylcholinesterase as Revealed by Photoaffinity Labeling with [3H]DDF. Biochemistry. 1998;37(29):10507\u201310513. doi: 10.1021/bi980536l.", "ArticleIdList": ["10.1021/bi980536l", "9671522"]}, {"Citation": "Brus B. Ko\u0161ak U. Turk S. Pi\u0161lar A. Coquelle N. Kos J. Stojan J. Colletier J.-P. Gobec S. Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor. J. Med. Chem. 2014;57(19):8167\u20138179. doi: 10.1021/jm501195e.", "ArticleIdList": ["10.1021/jm501195e", "25226236"]}, {"Citation": "Saxena A. Redman A. M. G. Jiang X. Lockridge O. Doctor B. P. Differences in Active-Site Gorge Dimensions of Cholinesterases Revealed by Binding of Inhibitors to Human Butyrylcholinesterase. Chem.-Biol. Interact. 1999;119\u2013120:61\u201369. doi: 10.1016/S0009-2797(99)00014-9.", "ArticleIdList": ["10.1016/S0009-2797(99)00014-9", "10421439"]}, {"Citation": "Radic Z. Pickering N. A. Vellom D. C. Camp S. Taylor P. Three Distinct Domains in the Cholinesterase Molecule Confer Selectivity for Acetyl- and Butyrylcholinesterase Inhibitors. Biochemistry. 1993;32(45):12074\u201312084. doi: 10.1021/bi00096a018.", "ArticleIdList": ["10.1021/bi00096a018", "8218285"]}, {"Citation": "Saxena A. Redman A. M. G. Jiang X. Lockridge O. Doctor B. P. Differences in Active-Site Gorge Dimensions of Cholinesterases Revealed by Binding of Inhibitors to Human Butyrylcholinesterase. Chem.-Biol. Interact. 1999;119\u2013120:61\u201369. doi: 10.1016/S0009-2797(99)00014-9.", "ArticleIdList": ["10.1016/S0009-2797(99)00014-9", "10421439"]}, {"Citation": "Andrisano V. Naldi M. de Simone A. Bartolini M. A Patent Review of Butyrylcholinesterase Inhibitors and Reactivators 2010\u20132017. Expert Opin. Ther. Pat. 2018;28(6):455\u2013465. doi: 10.1080/13543776.2018.1476494.", "ArticleIdList": ["10.1080/13543776.2018.1476494", "29757691"]}, {"Citation": "Sugimoto H., Takahashi J. and Takahashi T. H. I., Indoline derivatives, US20110294850, 2010"}, {"Citation": "University. MCKP of W., Novel hybrid cholinesterase inhibitors, WO2012165981A1, 2012"}, {"Citation": "\nBrus B., Ko\u0161ak U. and Knez D. C. N., Disubstituted piperidine derivatives as butyrylcholinesterase Accepted Manuscript inhibitors for use in the treatment of Alzheimer, WO2016151484, 2016, https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016151484"}, {"Citation": "Unlu S., Esiringu I. and Sahin Y.et al., 3-substituted-6h-benzo[c]chromen-6-ones and benzo[c] chromen-6-ones against senile dementia, WO2014129989A1, 2014"}, {"Citation": "Dastmalchi S. Hamzeh-Mivehroud M. Asadpour-Zeynali K. Comparison of Different 2D and 3-D QSAR Methods on Activity Prediction of Histamine H3 Receptor Antagonists. Iran J. Pharm. Res. 2012;11(1):97\u2013108.", "ArticleIdList": ["PMC3876572", "25317190"]}, {"Citation": "Verma J. Khedkar V. Coutinho E. 3-D QSAR in Drug Design - A Review. Curr. Top. Med. Chem. 2010;10(1):95\u2013115. doi: 10.2174/156802610790232260.", "ArticleIdList": ["10.2174/156802610790232260", "19929826"]}, {"Citation": "Greig N. H. Lahiri D. K. Sambamurti K. Butyrylcholinesterase An Important New Target in Alzheimer's Disease Therapy. Int. Psychogeriatr. 2002;14(S1):77\u201391. doi: 10.1017/S1041610203008676.", "ArticleIdList": ["10.1017/S1041610203008676", "12636181"]}, {"Citation": "Ahmed S. Khan S. T. Zargaham M. K. Khan A. U. Khan S. Hussain A. Uddin J. Khan A. Al-Harrasi A. Potential Therapeutic Natural Products against Alzheimer's Disease with Reference of Acetylcholinesterase. Biomed. Pharmacother. 2021;139:111609. doi: 10.1016/j.biopha.2021.111609.", "ArticleIdList": ["10.1016/j.biopha.2021.111609", "33915501"]}, {"Citation": "Cho S. J. Garsia M. L. S. Bier J. Tropsha A. Structure-Based Alignment and Comparative Molecular Field Analysis of Acetylcholinesterase Inhibitors. J. Med. Chem. 1996;39(26):5064\u20135071. doi: 10.1021/jm950771r.", "ArticleIdList": ["10.1021/jm950771r", "8978837"]}, {"Citation": "Nour H. Daoui O. Abchir O. ElKhattabi S. Belaidi S. Chtita S. Combined Computational Approaches for Developing New Anti-Alzheimer Drug Candidates: 3-D QSAR, Molecular Docking and Molecular Dynamics Studies of Liquiritigenin Derivatives. Heliyon. 2022;8(12):e11991. doi: 10.1016/j.heliyon.2022.e11991.", "ArticleIdList": ["10.1016/j.heliyon.2022.e11991", "PMC9761610", "36544815"]}, {"Citation": "Manouchehrizadeh E. Mostoufi A. Tahanpesar E. Fereidoonnezhad M. Alignment-Independent 3-D QSAR and Molecular Docking Studies of Tacrine-4-Oxo-4H-Chromene Hybrids as Anti-Alzheimer\u2019s Agents. Comput. Biol. Chem. 2019;80:463\u2013471. doi: 10.1016/j.compbiolchem.2019.05.010.", "ArticleIdList": ["10.1016/j.compbiolchem.2019.05.010", "31170562"]}, {"Citation": "Rastegari A. Safavi M. Vafadarnejad F. Najafi Z. Hariri R. Bukhari S. N. A. Iraji A. Edraki N. Firuzi O. Saeedi M. Mahdavi M. Akbarzadeh T. Synthesis and Evaluation of Novel Arylisoxazoles Linked to Tacrine Moiety: in vitro and in vivo Biological Activities against Alzheimer's Disease. Mol. Divers. 2022;26(1):409\u2013428. doi: 10.1007/s11030-021-10248-w.", "ArticleIdList": ["10.1007/s11030-021-10248-w", "34273065"]}, {"Citation": "Chehardoli G. Gholamhoseini P. Ebadi A. Ziaei M. Akbarzadeh T. Saeedi M. Mahdavi M. Khoshneviszadeh M. Najafi Z. 6-Methoxy-1-tetralone Derivatives Bearing an N-Arylpyridinium Moiety as Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Molecular Docking Study. ChemistrySelect. 2022;7(27):e202201977. doi: 10.1002/slct.202201977.", "ArticleIdList": ["10.1002/slct.202201977"]}, {"Citation": "Hasanvand Z. Motahari R. Nadri H. Moghimi S. Foroumadi R. Ayati A. Akbarzadeh T. Bukhari S. N. A. Foroumadi A. Novel 3-Aminobenzofuran Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease. Front. Chem. 2022:10. doi: 10.3389/fchem.2022.882191.", "ArticleIdList": ["10.3389/fchem.2022.882191", "PMC9395670", "36017161"]}, {"Citation": "Saeedi M. Maleki A. Iraji A. Hariri R. Akbarzadeh T. Edraki N. Firuzi O. Mirfazli S. S. Synthesis and Bio-Evaluation of New Multifunctional Methylindolinone-1,2,3-Triazole Hybrids as Anti-Alzheimer\u2019s Agents. J. Mol. Struct. 2021;1229:129828. doi: 10.1016/j.molstruc.2020.129828.", "ArticleIdList": ["10.1016/j.molstruc.2020.129828"]}, {"Citation": "Sadafi Kohnehshahri M. Chehardoli G. Bahiraei M. Akbarzadeh T. Ranjbar A. Rastegari A. Najafi Z. Novel Tacrine-Based Acetylcholinesterase Inhibitors as Potential Agents for the Treatment of Alzheimer's Disease: Quinolotacrine Hybrids. Mol. Divers. 2022;26(1):489\u2013503. doi: 10.1007/s11030-021-10307-2.", "ArticleIdList": ["10.1007/s11030-021-10307-2", "34491490"]}, {"Citation": "Kumar A. Loharch S. Kumar S. Ringe R. P. Parkesh R. Exploiting Cheminformatic and Machine Learning to Navigate the Available Chemical Space of Potential Small Molecule Inhibitors of SARS-CoV-2. Comput. Struct. Biotechnol. J. 2021;19:424\u2013438. doi: 10.1016/j.csbj.2020.12.028.", "ArticleIdList": ["10.1016/j.csbj.2020.12.028", "PMC7771909", "33391634"]}, {"Citation": "Jejurikar B. L. Rohane S. H. Drug designing in discovery studio. Asian J. Res. Chem. 2021;14(2):135\u2013138. doi: 10.5958/0974-4150.2021.00025.0.", "ArticleIdList": ["10.5958/0974-4150.2021.00025.0"]}, {"Citation": "Desmond Molecular Dynamics System, D. E. Shaw Research, Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY, 2021"}, {"Citation": "Halder A. K. Dias Soeiro Cordeiro M. N. Advanced in Silico Methods for the Development of Anti-Leishmaniasis and Anti-Trypanosomiasis Agents. Curr. Med. Chem. 2020;27(5):697\u2013718. doi: 10.2174/0929867325666181031093702.", "ArticleIdList": ["10.2174/0929867325666181031093702", "30378482"]}, {"Citation": "Gramatica P. Chirico N. Papa E. Cassani S. Kovarich S. QSARINS: A New Software for the Development, Analysis, and Validation of QSAR MLR Models. J. Comput. Chem. 2013;34(24):2121\u20132132. doi: 10.1002/jcc.23361.", "ArticleIdList": ["10.1002/jcc.23361"]}, {"Citation": "Kaserer T. Beck K. Akram M. Odermatt A. Schuster D. Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases. Molecules. 2015;20(12):22799\u201322832. doi: 10.3390/molecules201219880.", "ArticleIdList": ["10.3390/molecules201219880", "PMC6332202", "26703541"]}, {"Citation": "Sakkiah S. Lee K. W. Pharmacophore-Based Virtual Screening and Density Functional Theory Approach to Identifying Novel Butyrylcholinesterase Inhibitors. Acta Pharmacol. Sin. 2012;33(7):964\u2013978. doi: 10.1038/aps.2012.21.", "ArticleIdList": ["10.1038/aps.2012.21", "PMC4077067", "22684028"]}, {"Citation": "Kumar R. Son M. Bavi R. Lee Y. Park C. Arulalapperumal V. Cao G. P. Kim H. Suh J. Kim Y. Kwon Y. J. Lee K. W. Novel Chemical Scaffolds of the Tumor Marker AKR1B10 Inhibitors Discovered by 3-D QSAR Pharmacophore Modeling. Acta Pharmacol. Sin. 2015;36(8):998\u20131012. doi: 10.1038/aps.2015.17.", "ArticleIdList": ["10.1038/aps.2015.17", "PMC4564875", "26051108"]}, {"Citation": "Mali S. N. Pandey A. Bhandare R. R. Shaik A. B. Identification of Hydantoin Based Decaprenylphosphoryl-\u03b2-d-Ribose Oxidase (DprE1) Inhibitors as Antimycobacterial Agents Using Computational Tools. Sci. Rep. 2022;12(1):16368. doi: 10.1038/s41598-022-20325-1.", "ArticleIdList": ["10.1038/s41598-022-20325-1", "PMC9525719", "36180452"]}, {"Citation": "Dixon S. L. Smondyrev A. M. Rao S. N. PHASE: A Novel Approach to Pharmacophore Modeling and 3-D Database Searching. Chem. Biol. Drug Des. 2006;67(5):370\u2013372. doi: 10.1111/j.1747-0285.2006.00384.x.", "ArticleIdList": ["10.1111/j.1747-0285.2006.00384.x", "16784462"]}, {"Citation": "Varpe B. D. Jadhav S. B. Chatale B. C. Mali A. S. Jadhav S. Y. Kulkarni A. A. 3-D QSAR and Pharmacophore Modeling of 3,5-Disubstituted Indole Derivatives as Pim Kinase Inhibitors. Struct. Chem. 2020;31(5):1675\u20131690. doi: 10.1007/s11224-020-01503-1.", "ArticleIdList": ["10.1007/s11224-020-01503-1"]}, {"Citation": "Vijaya Prabhu S. Singh S. K. Atom-Based 3-D QSAR, Induced Fit Docking, and Molecular Dynamics Simulations Study of Thieno[2,3-b]Pyridines Negative Allosteric Modulators of MGluR5. J. Recept. Signal Transduction. 2018;38(3):225\u2013239. doi: 10.1080/10799893.2018.1476542.", "ArticleIdList": ["10.1080/10799893.2018.1476542", "29806525"]}, {"Citation": "Nachon F. Carletti E. Ronco C. Trovaslet M. Nicolet Y. Jean L. Renard P.-Y. Crystal Structures of Human Cholinesterases in Complex with Huprine W and Tacrine: Elements of Specificity for Anti-Alzheimer\u2019s Drugs Targeting Acetyl- and Butyryl-Cholinesterase. Biochem. J. 2013;453(3):393\u2013399. doi: 10.1042/BJ20130013.", "ArticleIdList": ["10.1042/BJ20130013", "23679855"]}, {"Citation": "Co\u015far E. D. Dincel E. D. Demiray S. Sucularl\u0131 E. T\u00fcccaro\u011flu E. \u00d6zsoy N. Ulusoy-G\u00fczeldemirci N. Anticholinesterase Activities of Novel Indole-Based Hydrazide-Hydrazone Derivatives: Design, Synthesis, Biological Evaluation, Molecular Docking Study and in Silico ADME Prediction. J. Mol. Struct. 2022;1247:131398. doi: 10.1016/j.molstruc.2021.131398.", "ArticleIdList": ["10.1016/j.molstruc.2021.131398"]}, {"Citation": "Asadi M. Ebrahimi M. Mohammadi-Khanaposhtani M. Azizian H. Sepehri S. Nadri H. Biglar M. Amanlou M. Larijani B. Mirzazadeh R. Edraki N. Mahdavi M. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer\u2019s Disease. Chem. Biodivers. 2019;16(11):5. doi: 10.1002/cbdv.201900370.", "ArticleIdList": ["10.1002/cbdv.201900370", "31523926"]}, {"Citation": "Yap C. W. PaDEL-Descriptor: An Open Source Software to Calculate Molecular Descriptors and Fingerprints. J. Comput. Chem. 2011;32(7):1466\u20131474. doi: 10.1002/jcc.21707.", "ArticleIdList": ["10.1002/jcc.21707", "21425294"]}, {"Citation": "Cao D.-S. Xu Q.-S. Hu Q.-N. Liang Y.-Z. ChemoPy: Freely Available Python Package for Computational Biology and Chemoinformatics. Bioinformatics. 2013;29(8):1092\u20131094. doi: 10.1093/bioinformatics/btt105.", "ArticleIdList": ["10.1093/bioinformatics/btt105", "23493324"]}, {"Citation": "Bento A. P. Hersey A. F\u00e9lix E. Landrum G. Gaulton A. Atkinson F. Bellis L. J. de Veij M. Leach A. R. An Open Source Chemical Structure Curation Pipeline Using RDKit. J. Cheminformatics. 2020;12(1):51. doi: 10.1186/s13321-020-00456-1.", "ArticleIdList": ["10.1186/s13321-020-00456-1", "PMC7458899", "33431044"]}, {"Citation": "Daina A. Michielin O. Zoete V. Swiss A. D. M. E.: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules. Sci. Rep. 2017;7(1):42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Daina A. Zoete V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem. 2016;11(11):1117\u20131121. doi: 10.1002/cmdc.201600182.", "ArticleIdList": ["10.1002/cmdc.201600182", "PMC5089604", "27218427"]}, {"Citation": "Masand V. H. Rastija V. Patil M. K. Gandhi A. Chapolikar A. Extending the Identification of Structural Features Responsible for Anti-SARS-CoV Activity of Peptide-Type Compounds Using QSAR Modelling. SAR QSAR Environ. Res. 2020;31(9):643\u2013654. doi: 10.1080/1062936X.2020.1784271.", "ArticleIdList": ["10.1080/1062936X.2020.1784271", "32847369"]}, {"Citation": "Hu Z. Lin Q. Liu H. Zhao T. Yang B. Tu G. Molecular Dynamics-Guided Receptor-Dependent 4D QSAR Studies of HDACs Inhibitors. Mol. Divers. 2022;26(2):757\u2013768. doi: 10.1007/s11030-021-10181-y.", "ArticleIdList": ["10.1007/s11030-021-10181-y", "33625673"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "25"}, {"Year": "2023", "Month": "3", "Day": "14"}, {"Year": "2023", "Month": "3", "Day": "27", "Hour": "3", "Minute": "19"}, {"Year": "2023", "Month": "3", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "3", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["36968055", "PMC10035067", "10.1039/d3ra00526g", "d3ra00526g"]}}], "PubmedBookArticle": []}